Companies · Listed company · 🇺🇸

Tempus AI, Inc.

TEM · US

Available company data, source links and archived checks for Tempus AI, Inc.. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.

Recorded quarterly figures
QuarterRevenue / incomeYoY ProfitYoYNet marginSource
Jun 2026Revenue: $382 mn—Net profit: $6 mn——Source details incomplete
Mar 2026Revenue: $348 mn—Net profit: $-126 mn——Source details incomplete
Dec 2025Revenue: $367 mn—Net profit: $-54 mn——Source details incomplete
Sep 2025Revenue: $334 mn—Net profit: $-80 mn——Source details incomplete
Jun 2025Revenue: $315 mn—Net profit: $-43 mn——Source details incomplete
Mar 2025Revenue: $256 mn—Net profit: $-68 mn——Source details incomplete

YoY means change from the same quarter a year earlier. — means no comparable figure is available. Older entries with incomplete source details have not been revalidated under the current checks.

The ownership tape — last 90 days, from disclosures
▼ Polovin Andrew (EVP, Chief Legal Officer) sold shares worth $444k · 19 Aug · SEC Form 4
▼ Schoenherr Thomas Edward (CEO, Diagnostics) sold shares worth $173k · 19 Aug · SEC Form 4
▼ Schoenherr Thomas Edward (CEO, Diagnostics) sold shares worth $29k · 19 Aug · SEC Form 4
▼ Schoenherr Thomas Edward (CEO, Diagnostics) sold shares worth $180k · 19 Aug · SEC Form 4
▼ Schoenherr Thomas Edward (CEO, Diagnostics) sold shares worth $54k · 19 Aug · SEC Form 4
▼ Schoenherr Thomas Edward (CEO, Diagnostics) sold shares worth $30k · 19 Aug · SEC Form 4
▼ Rogers James William (Chief Financial Officer) sold shares worth $1.6 million · 19 Aug · SEC Form 4
▼ Lefkofsky Eric P (10% owner) sold shares worth $6.6 million · 18 Aug · SEC Form 4
▼ Bartolucci Ryan M (Chief Accounting Officer) sold shares worth $306k · 18 Aug · SEC Form 4
▼ Polovin Andrew (EVP, Chief Legal Officer) sold shares worth $1.1 million · 18 Aug · SEC Form 4
▼ Fukushima Ryan (CEO, Data) sold shares worth $2.0 million · 18 Aug · SEC Form 4
▼ Rogers James William (Chief Financial Officer) sold shares worth $1.1 million · 18 Aug · SEC Form 4

Follow this company without reading every document yourself.

Keep its available filings, dated fact checks and disclosure alerts together. Your saved country sets your market and its research schedule.

Start free — first week on us →
India ₹149/month · Rest of world US$4.99/month after the free trial · research, not investment advice · cancel any time
Or just the free morning: three facts checked against filings, every trading day, in your inbox.
Related: 10x Genomics, Inc.1RT Acquisition Corp.1st Source Corporation22nd Century Group, IncAll companies →

Company data and archived claim checks are shown with available sources. Check the source and date before relying on a figure. This is not investment advice or a recommendation. Investment in securities markets is subject to market risks. Research on this site is produced with substantial use of AI. Terms, disclosures and grievances